1. Controlled trial of 1 a hydroxycholecalciferol in chronic renal failure;Tougaard, L.; S0rensen, E.; Br0chner-Mortensen, J.; Christensen, M.S.; R0dbro, P.; S0rensen, A.W.S.;Lancet,1976
2. Impairment of renal function in patients on 1 cc hydroxycholecalciferol (letter);Winterborn, M.H.; Mace, P.J.; Heath, D.A.; White, R.H.R.;Lancet,1978
3. Current status of the management;Fournier, A.; Sebert, J.L.; Coevoet, B.; De Fremont, J.F.; Hardin, J.M.; Lambrey, G.,1978
4. Effects of vitamin D metabolites and analogues on renal function;Naik, R.B.; Cundy, T.; Robinson, B.H.B.; Russell, R.G.G.; Kanis, J.A.;Nephron,1981
5. oc hydroxyvitamin D3 treatment of nondialyzed patients with chronic renal failure. Effects on bone, mineral metabolism and kidney function;Nielsen, H.E.; Romer, F.K.; Melsen, F.; Christensen, M.S.; Hansen, H.E.;Clin Nephrol; Comparison of effects of 1 a, hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in man,1980